Welcome to our dedicated page for Barclays news (Ticker: BCS), a resource for investors and traders seeking the latest updates and insights on Barclays stock.
Barclays PLC (BCS) is a global financial institution providing retail banking, investment services, and wealth management across 40+ countries. This news hub offers investors and stakeholders centralized access to verified corporate announcements and market-moving developments.
Track Barclays' latest earnings reports, leadership changes, strategic partnerships, and regulatory updates through official press releases and curated financial analysis. Our repository ensures timely access to material information affecting shareholder value, including dividend declarations and operational milestones.
Key coverage areas include quarterly financial results, capital management strategies, digital banking innovations, and sustainability initiatives. All content undergoes strict verification against primary sources including LSE regulatory filings and company disclosures.
Bookmark this page for direct access to Barclays' evolving market position within the competitive global banking sector. Check regularly for updates on cross-border transactions, risk management practices, and consumer banking trends shaping the financial services landscape.
Barclays Bank PLC has confirmed that there will be no changes to the constituents in the CIBC Atlas Select MLP Index during the quarterly rebalancing starting after October 8, 2021. The iPath Select MLP ETNs, linked to this Index, are traded on the CBOE BZX Exchange under the ticker symbol ATMP. Investors should be aware of the significant risks associated with these ETNs, including potential loss of principal, high volatility, and the absence of guaranteed coupon payments. The Index comprises 20 constituents from the Energy Sector, and its rebalancing methodology is based on credit ratings and trading volumes.
Barclays has appointed Gabriel Casillas as the new Chief Economist for Latin America, focusing on economic research and the Mexican economy from New York. Mr. Casillas, who has over 15 years of industry experience, previously served at Grupo Financiero Banorte as Chief Economist and Head of Investor Relations and ESG. He has held positions at J.P. Morgan and UBS, specializing in Mexico and Chile. His appointment reflects Barclays' commitment to enhancing its economic insights and capabilities.
Barclays Bank PLC has extended the expiration deadline for its cash tender offer to purchase iPath Bloomberg Natural Gas Subindex Total Return ETNs, now ending on October 14, 2021. The Purchase Price has increased by 50% from $0.10 to $0.15 per Note tendered. Noteholders who've already submitted tenders do not need to act again to benefit from the new price. As of September 29, 2021, 3,322,577 Notes, or 46.22% of outstanding Notes, have been tendered. The Offer is subject to market fluctuations, which may affect Note values significantly.
Barclays has appointed Naeem Merchant as Managing Director in Healthcare Investment Banking, effective October 2021. Based in New York, he will focus on the Pharmaceutical Services and IT sectors while reporting to Rick Landgarten. Mr. Merchant brings over 14 years of experience from Greenhill & Co. and Lehman Brothers, where he executed high-profile transactions. His addition is seen as a strategic move to enhance Barclays' Healthcare franchise, which has recently engaged in significant deals, including a $21bn acquisition by Thermo Fisher Scientific.
Barclays has appointed Amit Tyagi as a Managing Director in Healthcare Investment Banking, based in New York. With over 20 years of experience, Tyagi previously served as Head of Healthcare at Huatai Securities and Global Head of Medical Diagnostics and Life Sciences Tools at UBS. This appointment is expected to enhance Barclays' capabilities in the Tools and Diagnostics sector. The bank has been involved in significant transactions, including advising on $21 billion acquisition of PPD by Thermo Fisher Scientific and $3.4 billion sale of HMS to Gainwell Technologies.
Barclays Bank PLC announced it will not extend its Exchange Offer for iPath S&P GSCI Crude Oil Total Return Index ETNs due August 14, 2036. The Exchange Offer ended on August 31, 2021, with 92,211 Old Notes accepted, representing 18.33% of the total. The company also revealed preliminary results for the Tender Offer, where 40,891 Old Notes were accepted, equating to 8.13% of the outstanding notes. The expected total purchase price for these notes is approximately $5.05 million. Barclays anticipates not obtaining the necessary consents for proposed amendments in the Consent Solicitation.
Barclays Bank PLC has established a purchase price of $123.5398 for its cash tender offer to buy back its iPath® S&P GSCI® Crude Oil Total Return Index ETNs, due August 14, 2036. This price marks a 5% premium over the Closing Indicative Note Value of $117.6570 as of August 31, 2021. The tender offer and related consent solicitation expire at 11:59 p.m. New York City time on August 31, 2021, unless extended. Noteholders can opt for either a tender or an exchange offer for new ETNs, but simultaneous tenders are invalid.
Barclays Bank PLC has extended the expiration deadlines for its Exchange Offer and Cash Tender Offer concerning the iPath® S&P GSCI® Crude Oil ETNs. The Exchange Offer now expires on August 31, 2021, offering a 5.68% premium and an exchange ratio of six New Notes for each Old Note. The Cash Tender Offer sets a 105% purchase price based on the closing indicative note value as of the expiration date. Noteholders have tendered 67,611 Old Notes across both offers. The update emphasizes potential price fluctuations linked to the S&P GSCI Index performance.
Barclays Bank PLC has extended the expiration deadlines for its Exchange Offer and Tender Offer for the iPath® S&P GSCI® Crude Oil Total Return Index ETNs. The Exchange Offer will now expire on August 27, 2021, while the Tender Offer will expire at 11:59 p.m. on August 27, 2021. Noteholders can exchange Old Notes for New Notes at a premium of approximately 6%. A total of 126,431 Old Notes have been tendered as of the original deadline. The Purchase Price for the Tender Offer has been set at 105% of the Closing Indicative Note Value.
FAQ
What is the current stock price of Barclays (BCS)?
What is the market cap of Barclays (BCS)?
